Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abiomed Inc (NASDAQ:ABMD)

191.36
Delayed Data
As of Dec 08
 +3.45 / +1.84%
Today’s Change
103.53
Today|||52-Week Range
200.28
+69.83%
Year-to-Date

Today’s Trading

Previous close187.91
Today’s open188.01
Day’s range187.95 - 191.40
Volume273,136
Average volume (3 months)333,352
Market cap$8.5B
Dividend yield--
Data as of 4:00pm ET, 12/08/2017

Growth & Valuation

Earnings growth (last year)+37.65%
Earnings growth (this year)+99.57%
Earnings growth (next 5 years)+41.50%
Revenue growth (last year)+35.13%
P/E ratio93.8
Price/Sales12.56
Price/Book18.49

Competitors

 Today’s
change
Today’s
% change
DXCMDexCom Inc+1.56+2.60%
WSTWest Pharmaceutical ...+0.02+0.02%
MASIMasimo Corp+0.48+0.56%
IARTIntegra LifeSciences...+0.84+1.75%
Data as of 4:15pm ET, 12/08/2017

Financials

Next reporting dateFebruary 1, 2018
EPS forecast (this quarter)$0.50
Annual revenue (last year)$445.3M
Annual profit (last year)$52.1M
Net profit margin11.70%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Michael R. Minogue
Chief Operating Officer
David M. Weber
Corporate headquarters
Danvers, Massachusetts

Forecasts